Literature DB >> 35958486

Development and validation of a nomogram to predict recurrence in children with Henoch-Schönlein purpura.

Danyang Song1, Yajing Jiang2, Qiuju Zhao2, Jinling Li2.   

Abstract

BACKGROUND: To screen risk factors for the recurrence in children with Henoch-Schönlein Purpura (HSP) and to develop and validate a nomogram for recurrence in children with HSP.
METHODS: During September 2019 and September 2021, 212 children with HSP were selected in this study. The children were divided into two sets in a proportion of 7:3 using R language, with the first group as the training sets and the second as the internal validation sets. The related variables were analyzed by univariate and multivariate logistic regression analyses, and a nomogram for predicting the recurrence in HSP children was established. The nomogram was evaluated by ROC curve, calibration curve and decision curve, and 1000 times bootstrap resampling method was used to verify the model internally.
RESULTS: Univariate and multivariate regression analyses identified respiratory infection, without preventive medication and diet restriction, age, allergen positive and abnormal urine routine as risk factors for the recurrence in children with HSP. Those risk factors were used to construct a predictive nomogram. The calibration curves revealed excellent accuracy of the predictive nomogram model, internally and externally.
CONCLUSIONS: We constructed and validated a clinical nomogram to predict the recurrence in children with HSP. We confirmed that respiratory tract infection, without preventive medication and diet restriction, age, allergen positive and abnormal urine routine were independent recurrence risk factors. This nomogram had a good performance in clinical decision-making. AJTR
Copyright © 2022.

Entities:  

Keywords:  Henoch-Schönlein purpura; nomogram; recurrence; risk predictors

Year:  2022        PMID: 35958486      PMCID: PMC9360896     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  45 in total

1.  Henoch-Schönlein purpura associated with pidotimod therapy.

Authors:  L Cantarini; A Brogna; A Fioravanti; M Galeazzi
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

Review 2.  Relapsing Henoch-Schönlein purpura associated with Pseudomonas aeruginosa pyelonephritis.

Authors:  C A Egan; M A O'Reilly; K P Meadows; J J Zone
Journal:  J Am Acad Dermatol       Date:  2000-02       Impact factor: 11.527

3.  A Kidney Transplant Recipient with Recurrent Henoch-Schönlein Purpura Nephritis Successfully Treated with Steroid Pulse Therapy and Epipharyngeal Abrasive Therapy.

Authors:  Mika Fujimoto; Kan Katayama; Kouhei Nishikawa; Shoko Mizoguchi; Keiko Oda; Yosuke Hirabayashi; Yasuo Suzuki; Ayumi Haruki; Takayasu Ito; Tomohiro Murata; Eiji Ishikawa; Yoshiki Sugimura; Masaaki Ito
Journal:  Nephron       Date:  2020-11-20       Impact factor: 2.847

4.  Changes in clinical features in Henoch-Schönlein purpura during three decades: an observational study at a single hospital in Korea.

Authors:  Jung-Woo Rhim; Yoon-Tae Lee; Hyun-Mi Kang; Jin-Soon Suh; Kyung-Yil Lee
Journal:  Clin Rheumatol       Date:  2019-06-08       Impact factor: 2.980

5.  Characterization of scrotal involvement in children and adolescents with IgA vasculitis.

Authors:  Izabel M Buscatti; Henrique M Abrão; Katia Kozu; Victor L S Marques; Roberta C Gomes; Adriana M E Sallum; Clovis A Silva
Journal:  Adv Rheumatol       Date:  2018-11-03

6.  Renal allograft glomerulopathy and the value of immunohistochemistry.

Authors:  P M Freese; C T Svalander; J Mölne; G Nyberg
Journal:  Clin Nephrol       Date:  2004-10       Impact factor: 0.975

7.  Real-time vascular and IgA dynamics during Henoch-Schönlein purpura by in vivo fluorescent microscopy.

Authors:  Yujie Zhu; Shaoyang Wang; Hui Xu; Hao He; Meng Pan
Journal:  Biomed Opt Express       Date:  2021-11-29       Impact factor: 3.732

8.  [Analysis of clinical characteristics of Henoch-Schonlein purpura patients from different altitudes in plateau areas].

Authors:  H Wei; Z Luo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

9.  Clinical application of compound Glycyrrhizin tablets in the treatment of patients with Simplex Henoch-Schonlein Purpura and its effect on immune function.

Authors:  Chao Li; Zhi-Bin Wang
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

10.  Integrated Analyses of Gut Microbiome and Host Metabolome in Children With Henoch-Schönlein Purpura.

Authors:  Min Wen; Xiqiang Dang; Shipin Feng; Qingnan He; Xiaoyan Li; Taohua Liu; Xiaojie He
Journal:  Front Cell Infect Microbiol       Date:  2022-01-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.